Cherry Hill, NJ, United States of America

Parth Modi

This inventor holds 1 USPTO granted patent. Top assignee: University System of Maryland. Active years: 2014.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Parth Modi: Innovator in Cyclic Acetal Biomaterials

Introduction

Parth Modi is an accomplished inventor based in Cherry Hill, NJ (US). He has made significant contributions to the field of biomaterials, particularly through his innovative work on cyclic acetal biomaterials. His research focuses on developing materials that can be utilized in various biological applications, including orthopedic procedures.

Latest Patents

Parth Modi holds a patent for a novel class of cyclic acetal biomaterials (CABs). This patent, titled "Cyclic Acetal Biomaterials," discloses and claims two innovative biomaterials suitable for use in joint and cartilage replacement and/or repair, as well as bone cement. The biomaterials consist of a network of monomers of 5-ethyl-5-(hydroxymethyl)-β,β-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD) and a hydrogel made up of EHD and poly(ethylene glycol) diacrylate (PEG-EHD). This invention represents a significant advancement in the field of biomaterials.

Career Highlights

Parth Modi is affiliated with the University System of Maryland, where he continues to engage in research and development of innovative biomaterials. His work has garnered attention for its potential applications in medical fields, particularly in improving patient outcomes in orthopedic surgeries.

Collaborations

Parth has collaborated with notable colleagues, including Sachiko Kaihara and Jennifer Lynn Moreau. These partnerships have contributed to the advancement of his research and the development of new biomaterials.

Conclusion

Parth Modi is a pioneering inventor whose work in cyclic acetal biomaterials is paving the way for advancements in medical applications. His contributions to the field are noteworthy and hold promise for future innovations in orthopedic medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…